AI large model-driven drug discovery CRO Diagram

Strengths

• Possesses proprietary AI large models and rich biological data
• Mature wet-lab platform and cases of collaboration with pharmaceutical companies

Weaknesses

• High R&D investment and long cycles
• AI model generalization capability is constrained by data quality

Opportunities

• Rapid growth in the AI drug discovery market and policy support
• Expanding outsourcing demand from global pharmaceutical companies

Threats

• Traditional CROs are accelerating AI transformation, and competition is intense
• Regulation of biological data privacy is tightening

Workflow diagram • Built with Archify • Create yours ↗ • Hover to trace • R route • Click to focus • +/− zoom • M radar • T theme • E export